10x Genomics (TXG) Other Operating Expenses (2018 - 2025)

10x Genomics has disclosed Other Operating Expenses across 6 years of filings, most recently posting -$40.7 million for Q2 2025.

• Other Operating Expenses for Q2 2025 came in at -$40.7 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was -$40.7 million (down 342.39% YoY), and the FY2025 annual result was -$49.9 million, changed N/A from the prior year.
• Other Operating Expenses came in at -$40.7 million for Q2 2025 at 10x Genomics, down from -$9.2 million in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of $41.4 million in Q3 2023 to a low of -$40.7 million in Q2 2025.
• The 3-year median for Other Operating Expenses is -$330000.0 (2021), against an average of $1.7 million.
• Peak annual rise in Other Operating Expenses reached 37.09% in 2021, while the deepest fall reached 363.98% in 2021.
• 10x Genomics' Other Operating Expenses stood at -$850000.0 in 2021, then surged by 2403.29% to $19.6 million in 2023, then sank by 307.89% to -$40.7 million in 2025.
• The last three Other Operating Expenses figures came in at -$40.7 million (Q2 2025), -$9.2 million (Q1 2025), and $19.6 million (Q4 2023), per Business Quant data.